Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6.82 USD
−11.75 M USD
1.80 M USD
819.12 K
About ADDEX N
Sector
CEO
Timothy Dyer
Headquarters
Geneva
Website
Founded
2002
FIGI
BBG00R48ST95
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.